Facebook
X
LinkedIn
ForwardTherapies and Biomarkers in Advanced Renal Cancer
Learning Objectives:
- Summarize current clinical management in kidney cancer.
- Define biomarkers in kidney cancer.
- Review novel therapies and approaches in kidney cancer management.
Ulka Vaishampayan, M.D.
Director of Phase I Therapeutics, Rogel Cancer Institute, Professor of Medicine, University of Michigan School of Medicine, Anne Arbor, MI
LOCATION: Virtual Only, via Zoom
Register in advance for this webinar using the link below:
After registering, you will receive a confirmation email containing information about joining the webinar.
_____________________________________________________________________________________________________________________
ABOUT Cancer Center Grand Rounds held weekly on Thursdays for faculty and junior faculty, investigators and junior investigators, scholars, graduate students, medical students, research fellows, administration and allied health staff. Credit Statement(s)In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medicine Education (ACCME), the Accreditation Council of Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCCP) to provide continuing education for the healthcare team. AMA The Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. ATTENDANCE A unique presentation code must be sent via text to 507-200-3010 to record attendance and to ensure you receive CME credit for your attendance. NOTE: Attendees must be present to receive code. ARCHIVED PRESENTATIONS Arizona Cancer Center Grand Rounds video library. |